Leveraging LIS Data in Your Market Access Strategy

Our Managing Director, Tate Rarick, discusses the latest updates in LIS enrollment data, the strategic value of the data to market access teams and pharma brands, and how best to deploy its use to improve patient access.

Learning Objectives

• Learn about the latest updates in LIS enrollment data, including sources and availability, patterns of enrollment, plan types and trends, and LIS hotspots
• Understand the access implications for low-income patients and the importance of utilizing LIS data in your market access strategies
• Identify the difficulties in locating LIS patient hotspot and how to overcome the challenges
• See how a market access platform optimizes the implementation of LIS data from territory visibility to pre-call planning and HCP messaging

Want to learn more?

Contact us to learn how we can help your team achieve your market access goals.